Evidence map›Paper›PMID 41200576›Full record

ArticleBalkan journal of medical genetics : BJMG2025

Qualitative and Quantitative Aspects of Discrepancies between Various Methods for Microsatellite Instability Detection.

M Staninova-Stojovska, N Matevska-Geshkovska, E Krstevska-Bozhinovikj, R Jovanovic, K Kubelka Sabit, B Angelovska, N Mitreski, P Noveski, A Dimovski

Abstract read
In one paragraph

Article in Balkan journal of medical genetics : BJMG, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

M Staninova-StojovskaCenter for Biomolecular Pharmaceutical Analysis, Faculty of Pharmacy, University "Ss. Cyril and Methodius" in Skopje, RN Macedonia.
N Matevska-GeshkovskaCenter for Biomolecular Pharmaceutical Analysis, Faculty of Pharmacy, University "Ss. Cyril and Methodius" in Skopje, RN Macedonia.
E Krstevska-BozhinovikjCenter for Biomolecular Pharmaceutical Analysis, Faculty of Pharmacy, University "Ss. Cyril and Methodius" in Skopje, RN Macedonia.
R JovanovicInstitute of Pathology, Faculty of Medicine, University "Ss. Cyril and Methodius" in Skopje, RN Macedonia.
K Kubelka SabitClinical Hospital "Acibadem Sistina", Skopje, RN Macedonia.
B AngelovskaUniversity Clinic for Radiotherapy and Oncology, Faculty of Medicine, University "Ss. Cyril and Methodius" in Skopje, RN Macedonia.
N MitreskiUniversity Clinic for Radiotherapy and Oncology, Faculty of Medicine, University "Ss. Cyril and Methodius" in Skopje, RN Macedonia.
P NoveskiResearch Center for Genetic Engineering and Biotechnology "Georgi D. Efremov", Macedonian Academy of Sciences and Arts, Skopje, RN Macedonia.
A DimovskiCenter for Biomolecular Pharmaceutical Analysis, Faculty of Pharmacy, University "Ss. Cyril and Methodius" in Skopje, RN Macedonia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The discordance rate of the results between immunohistochemistry (IHC) and molecular microsatellite instability (MSI-PCR) tests, the most commonly used methods for qualitative deficient mismatch repair (dMMR) testing, is 1-10%, highlighting the need for a more precise testing strategy. The next-generation sequencing (NGS) offers a more sensitive and effective dMMR analysis (MSI-NGS), which also provides quantitative data. The aim of the study was to evaluate the qualitative and quantitative aspects of IHC and MSI-PCR testing compared to MSI-NGS in detecting dMMR in patients with Lynch Syndrome (LS)-associated and sporadic colorectal (CRC) and endometrial cancers (EC). Our results demonstrate both qualitative and quantitative discrepancies in the results obtained with different methods. Regarding qualitative differences, dMMR was inadequately interpreted only in LS when relying solely on IHC or MSI-PCR testing. This was primarily due to the specific mutational profile in our population, indicating the need for the implementation of a specific strategy that combines both methods. Concerning the quantitative differences, we detected great variability in the MSI levels, which was partly attributed to the tissue type or to the type of mutation in LS patients. Our results suggest that MSI-NGS level could be used as a potential surrogate marker for neoantigen levels and provide more precise predictive information for immunotherapy in patients with dMMR deficiency.

Identifiers

PMID41200576
PMCPMC12588059

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.